GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OTCPK:CLPBY) » Definitions » Cyclically Adjusted FCF per Share

Coloplast A/S (Coloplast A/S) Cyclically Adjusted FCF per Share : $0.23 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Coloplast A/S's adjusted free cash flow per share for the three months ended in Mar. 2024 was $-0.184. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.23 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Coloplast A/S's average Cyclically Adjusted FCF Growth Rate was -4.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Coloplast A/S was 9.70% per year. The lowest was 6.80% per year. And the median was 8.35% per year.

As of today (2024-06-11), Coloplast A/S's current stock price is $12.24. Coloplast A/S's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.23. Coloplast A/S's Cyclically Adjusted Price-to-FCF of today is 53.22.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast A/S was 86.54. The lowest was 41.66. And the median was 59.07.


Coloplast A/S Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted FCF per Share Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.22 0.23 0.22 0.24

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.24 0.24 0.25 0.23

Competitive Comparison of Coloplast A/S's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted Price-to-FCF falls into.



Coloplast A/S Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast A/S's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.184/118.4000*118.4000
=-0.184

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.072 99.700 0.086
201409 0.081 99.700 0.096
201412 0.038 99.400 0.045
201503 0.003 100.200 0.004
201506 0.069 100.300 0.081
201509 0.086 100.200 0.102
201512 0.035 99.800 0.042
201603 0.025 100.200 0.030
201606 0.032 100.600 0.038
201609 0.076 100.200 0.090
201612 0.009 100.300 0.011
201703 0.010 101.200 0.012
201706 0.068 101.200 0.080
201709 0.099 101.800 0.115
201712 0.061 101.300 0.071
201803 0.022 101.700 0.026
201806 0.087 102.300 0.101
201809 0.105 102.400 0.121
201812 0.046 102.100 0.053
201903 0.023 102.900 0.026
201906 0.086 102.900 0.099
201909 0.107 102.900 0.123
201912 0.056 102.900 0.064
202003 0.025 103.300 0.029
202006 0.086 103.200 0.099
202009 0.107 103.500 0.122
202012 -0.001 103.400 -0.001
202103 0.039 104.300 0.044
202106 0.088 105.000 0.099
202109 0.124 105.800 0.139
202112 0.066 106.600 0.073
202203 -0.001 109.900 -0.001
202206 0.088 113.600 0.092
202209 0.109 116.400 0.111
202212 0.014 115.900 0.014
202303 0.027 117.300 0.027
202306 0.060 116.400 0.061
202309 0.095 117.400 0.096
202312 0.101 116.700 0.102
202403 -0.184 118.400 -0.184

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Coloplast A/S  (OTCPK:CLPBY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast A/S's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=12.24/0.23
=53.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Coloplast A/S was 86.54. The lowest was 41.66. And the median was 59.07.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Coloplast A/S Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (Coloplast A/S) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (Coloplast A/S) Headlines

From GuruFocus

Coloplast A/S's Dividend Analysis

By GuruFocus Research 12-07-2023